These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 7155880)

  • 1. [Effect of hormonal contraception on the course of lupus nephropathy].
    Jungers P; Dougados M; Pélissier C; Kuttenn F; Tron F; Pertuiset N; Bach JF
    Nouv Presse Med; 1982 Dec; 11(51):3765-8. PubMed ID: 7155880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Hormonal contraception and lupus].
    Jungers P; Liote F; Dehaine V; Dougados M; Viriot J; Pelissier C; Kuttenn F
    Ann Med Interne (Paris); 1990; 141(3):253-6. PubMed ID: 1695073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of oral contraceptive therapy on the activity of systemic lupus erythematosus.
    Jungers P; Dougados M; Pélissier C; Kuttenn F; Tron F; Lesavre P; Bach JF
    Arthritis Rheum; 1982 Jun; 25(6):618-23. PubMed ID: 7092961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Contraception in women suffering from systemic lupus ethymatosus].
    Musson P; Serfaty D; Puissant A
    Contracept Fertil Sex (Paris); 1985 Oct; 13(10):1063-7. PubMed ID: 12267711
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral contraceptive therapy and systemic lupus erythematosus.
    Travers RL; Hughes GR
    J Rheumatol; 1978; 5(4):448-51. PubMed ID: 310887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hormonal therapy in systemic lupus erythematosus].
    Kaliterna DM; Krstulović DM; Radić M
    Reumatizam; 2009; 56(2):41-3. PubMed ID: 20429261
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Pharmacological aspects of oral contraceptives (author's transl)].
    Weil-levy C; Soubrie C; Simon P
    Contracept Fertil Sex (Paris); 1980 Feb; 8(2):123-7. PubMed ID: 12336185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. European Society of Contraception oral contraceptives survey update: birth control methods in "Europe of the 12".
    Serfaty D; Wildemeersch D; Verougstraete A; Creatsas G
    Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():73-9. PubMed ID: 8574253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cutaneous effects in hormonal contraception].
    Thomas P; Dalle E; Revillon B; Delecour M; Devarenne-nicolle MF; Pagniez I
    NPN Med; 1985 Jan; 5(81):19-24. PubMed ID: 12281276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogens in oral contraceptives: historical perspectives.
    Goldzieher JW
    Johns Hopkins Med J; 1982 May; 150(5):165-9. PubMed ID: 7043034
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rationale for prescribing oral contraceptives].
    Teichmann AT
    Wien Med Wochenschr; 1998; 148(7):171-4. PubMed ID: 9700865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in haemostatic variables induced by oral contraceptives containing 50 micrograms or 30 micrograms oestrogen: absence of dose-dependent effect on PAI-1 activity.
    Scarabin PY; Plu-Bureau G; Zitoun D; Bara L; Guize L; Samama MM
    Thromb Haemost; 1995 Sep; 74(3):928-32. PubMed ID: 8571323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Contraception with the latest estroprogestagens in women suffering from systemic lupus erythematosus.
    Rampone A; Rampone B; Tirabasso S; Panariello S; Rampone N; Vozza A; Vozza G
    Minerva Ginecol; 2001 Feb; 53(1 Suppl 1):75-7. PubMed ID: 11526727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thirty years after the appearance of the first oral contraceptive, clinical and biological analysis of a new estrogen-progestin combination, a three phase pill containing gestodene].
    Belaisch J; Hommais-loufrani B
    Fertil Contracept Sex; 1988 Apr; 16(4 Suppl):1-8. PubMed ID: 12342078
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A trial of contraceptive methods in women with systemic lupus erythematosus.
    Sánchez-Guerrero J; Uribe AG; Jiménez-Santana L; Mestanza-Peralta M; Lara-Reyes P; Seuc AH; Cravioto MD
    N Engl J Med; 2005 Dec; 353(24):2539-49. PubMed ID: 16354890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Influence of progestins on adverse effects of oral contraceptives].
    Wynn V
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):425-30. PubMed ID: 12280210
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Individualization of low-dose oral contraceptives. Pharmacological principles and practical indications for oral contraceptives].
    Cianci A; De Leo V
    Minerva Ginecol; 2007 Aug; 59(4):415-25. PubMed ID: 17923832
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Contraception after heart transplantation].
    Spina V; Aleandri V; Salvi M
    Minerva Ginecol; 1998 Dec; 50(12):539-43. PubMed ID: 10069168
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dermatological complications caused by oral contraceptives].
    Deharo C; Berbis P; Privat Y
    Fertil Contracept Sex; 1988 Apr; 16(4):299-304. PubMed ID: 12342376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Veins and contraception].
    Reinharez D; Monsonego J
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):131-6. PubMed ID: 12280199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.